Recently, the Institute for Clinical and Economic Review (ICER), released a scoping document outlining its intentions to evaluate the cost effectiveness of drugs used to treat the autoimmune disease Rheumatoid…
By: Rev. Derek McCoy | The Orlando Advocate Heart disease is the longstanding No. 1 killer of Americans, and the leading cause of death among Marylanders. While this silent killer…
By: Mark Terry | BioSpace.com Speaking yesterday at the Financial Times U.S. Healthcare & Life Sciences Summit, Leonard Schleifer, chief executive officer of Regeneron Pharmaceuticals, sharply criticized the results of a report written by Boston-based Institute…